Signaling in T cells – is anything the m(a)TOR with the picture(s)? [version 1; referees: 4 approved]

Signaling in T cells – is anything the m(a)TOR with the picture(s)? [version 1; referees: 4 approved]

The excitement surrounding checkpoint inhibitors in the treatment of patients with cancer exemplifies a triumph of the long-term value of investing in basic science and fundamental questions of T-cell signaling. The pharmaceutical future actively embraces ways of making more patients’ cancers respon...

Full description

Bibliographic Details
Main Author: Mark Boothby
Format: Article
Language:English
Published: F1000 Research Ltd 2016-02-01
Series:F1000Research
Subjects:
Antigen Processing & Recognition
Biocatalysis
Cancer Therapeutics
Chemical Biology of the Cell
Drug Discovery & Design
Endocrinology
Immune Response
Immunity to Infections
Immunomodulation
Immunopharmacology & Hematologic Pharmacology
Innate Immunity
Leukocyte Activation
Leukocyte Development
Leukocyte Signaling & Gene Expression
Molecular Pharmacology
Online Access:http://f1000research.com/articles/5-191/v1

Internet

http://f1000research.com/articles/5-191/v1

Similar Items